Stocks
Voyager Therapeutics, Inc.VYGR
NASDAQHealthcareBiotechnology$1.74
Price as of · delayed, not real-time
A clinical-stage gene therapy company focused on developing treatments for severe neurological diseases, including Parkinson's and Huntington's disease. Its lead programs target the central nervous system using adeno-associated virus vectors, and investors track it for the potential of its drug candidates and its partnerships with larger pharmaceutical companies.
52W Range: $1.74-$5.48
Congressional Interest in Voyager Therapeutics, Inc. (VYGR)
No congressional trades have been disclosed for Voyager Therapeutics, Inc. (VYGR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VYGR?
No congressional trades found for this stock.